Home » Topics » Regulatory » Patents

Patents
RSS

Angiotensin II antagonists described by Kotobuki Seiyaku

July 19, 1996

No Comments

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

No Comments

Muscarinic cholinergic ligands described by Novo Nordisk

July 19, 1996

No Comments

Neurogen reveals D3/D4 receptor-selective compounds

July 19, 1996

No Comments

5-HT1A receptor-selective agents from American Home Products

July 19, 1996

No Comments

Cholesterol absorption inhibitors from Schering-Plough

July 19, 1996

No Comments

Bile acid reabsorption inhibitors described by Glaxo Wellcome

July 19, 1996

No Comments

Cathepsin L inhibitors described by Takeda

July 19, 1996

No Comments

Vitamin D compounds with preferencial calcemic and cell differation inducing activity described

July 19, 1996

No Comments

O6-alkylguanine-DNA alkyltransferase inactivators disclosed

July 19, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Patents
RSS

Angiotensin II antagonists described by Kotobuki Seiyaku

5-Lipoxygenase inhibitors reported by Pfizer

Muscarinic cholinergic ligands described by Novo Nordisk

Neurogen reveals D3/D4 receptor-selective compounds

5-HT1A receptor-selective agents from American Home Products

Cholesterol absorption inhibitors from Schering-Plough

Bile acid reabsorption inhibitors described by Glaxo Wellcome

Cathepsin L inhibitors described by Takeda

Vitamin D compounds with preferencial calcemic and cell differation inducing activity described

O6-alkylguanine-DNA alkyltransferase inactivators disclosed

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes

Patents RSS

Patents
RSS